Delivery Order SPE2DX22D0010-SPE2D826FCU31
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $3,054.37 for Focalin XR (dexmethylphenidate) 10 mg capsules on January 23, 2026, with completion scheduled for January 26, 2026. The award was issued by the Defense Logistics Agency Medical Supply Chain to support federal pharmaceutical procurement needs. The delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet open...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of 4,562,724,889 units of FOCALIN XR 30 MG CAPSULE 100S. The firm-fixed-price contract, valued at $6,172.36, has a completion date of November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
- This delivery order, issued January 8, 2026, awards Amerisourcebergen Drug Corp $2,427.63 for the supply of Focalin XR Caps 20mg under a firm fixed-price contract. The award was competitively procured with no set-aside designation and is scheduled for completion by January 9, 2026. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The funding agency is the Defense Logistics Agency...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,845.06 firm fixed-price delivery order is for the supply of 4,560,824,177 units of Focalin XR 10 mg capsules. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,269.20 for 4562082712 - FOCALIN XR 20 MG CAPSULE 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on September 7, 2023, with a completion date of September 8, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,630.74, is for the delivery of Focalin XR 10mg capsules. It was awarded on November 30, 2023, with a completion date of December 1, 2023. The contract type is Firm Fixed Price, and it was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 2, 2025, for Focalin XR Caps 15mg with a ceiling value of $1,100.24. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, indicating competitive award. The contract supports federal medical procurement needs,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,744.02 for the supply of Focalin XR 5 mg capsules. The award has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,251.85 firm fixed-price delivery order is for the supply of FOCALIN XR 20 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- AmerisourceBergen Drug Corp was awarded a delivery order for Focalin XR Caps 10mg valued at $1,125.94 by the Medical Supply Chain division of the Defense Logistics Agency on November 6, 2025. The contract utilizes firm fixed pricing with an ultimate completion date of November 7, 2025, and no set-aside designation was applied. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCU31Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, for Focalin XR Caps 10mg with a ceiling value of $4,001.14. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 29, 2026, and carries no set-aside designation, indicating it was awarded through open competition. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency component responsible for pharmaceutical procurement to support military healthcare systems. This delivery order is issued under Cencora's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and veterans' healthcare programs worldwide. The performance location is Cencora's corporate office in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution operations serving federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/27/26 |